Regulations

Hitex & P.L. Thomas

Paris, France-based Hitex, a subsidiary of Lavipharm Group, and P.L. Thomas, Morristown, NJ, have received a letter of no objection from FDA regarding new dietary ingredient (NDI) status for Lipowheat oil natural ceramides. Patented and scientifically supported by three clinical studies, Lipowheat oral delivery of ceramides restores the skin barrier function, ensuring a healthy hydration mechanism, according to the companies. P.L. Thomas is the exclusive marketer for Lipowheat in North America.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters